As AI accelerates across clinical, operational, and administrative workflows, healthcare leaders face a defining challenge: How do we harness AI-driven innovation while safeguarding ethics, equity, regulatory integrity, and patient trust? Join us for an exclusive, executive‑level discussion with leading voices in Healthcare AI Governance as we examine the best practices and common governance pitfalls that shape responsible clinical AI adoption.
This strategic discussion will explore emerging governance frameworks, evolving CMS and regulatory expectations, and the growing importance of transparent, bias-aware, explainable, and continuously validated AI systems. Attendees will gain insights into how governance decisions made today will directly impact clinical outcomes, workforce confidence, enterprise risk, and long‑term organizational resilience.
Drawing from real‑world experiences shared by healthcare CXOs, investors, and clinical leaders, this session will highlight governance gaps surfaced by early AI adopters and outline a stewardship‑driven roadmap for building accountable, trustworthy AI programs across healthcare enterprises.
Join us for “Healthcare AI Governance: Best Practices and Pitfalls from Strategy to Adoption.” This executive‑level session brings together healthcare leaders for a strategic discussion on the essential role of disciplined governance, ethical stewardship, and regulatory alignment in responsible AI adoption across clinical and operational workflows. Participants will gain practical insight into navigating governance challenges while enabling innovation at scale. Attendees will leave with two executive frameworks: a healthcare‑aligned AI governance blueprint defining oversight, accountability, and continuous validation; and a boardroom‑ready governance and prioritization model to assess risk, bias, explainability, and compliance.
Deepak Mittal, MBA, MS, FRM
(Moderator)
is an accomplished serial entrepreneur with a proven track record in product, AI, and data strategy. He is experienced in transforming an organization into an insight-driven, AI-enabled organization. Currently, Deepak holds the Founder & CEO position of NextGen Invent Corporation, a leading global professional services company that has consistently been at the forefront of providing solutions using disruptive technologies such as Agentic AI, Computer Vision, and Intelligent Automation. During his career, Deepak has served as a member of the Board of Directors of many companies, including D4DT, Optym, CMR Institute, CBS Alum Club of New York, and Launch Right Now. He is a strategic advisor to various organizations that grew from small start-ups to a unicorn or had successful exits. Deepak holds expertise in evaluating new product ideas, devising an appropriate product and AI strategy, transforming organizations into insight-driven organizations, and structuring strategic partnerships. Deepak has an MBA from Columbia Business School and an M.S. in Industrial Management Engineering from the Indian Institute of Technology. 
Michael Bouton M.D, M.B.A
(Speaker)
is practicing emergency medicine physician and the Chief Health Information Officer of the largest municipal health system in the country. His passion is integrating the financial, operational, clinical, and technological aspects of hospital administration in pursuit of improving the care of the underserved. Prior to working at NYC H+H, Michael received the class Humanism Award from the Columbia College of Physicians and Surgeons and served as the first director of a homeless health clinic. He completed residency in the Harvard Emergency Medicine Program at Beth Israel Deaconess, where he received the teaching award as a senior resident and then again as an attending after joining NYC H+H. 
Dr. Alexander J. Blood, MD, MSc, FACC, ABOM
(Speaker)
is a Physician-scientist, clinical trialist, and digital health innovator working at the forefront of cardiometabolic disease, critical care, and AI in healthcare. He is a Cardiologist and Critical Care Attending at Brigham and Women’s Hospital and an instructor of medicine at Harvard Medical School. Dr. Blood also serves as Senior Clinical Investigator at the Mass General Brigham Data Science Office and Associate Director of the Accelerator for Clinical Transformation. He is the CEO and co-founder of AIwithCare, a company that utilizes generative AI to transform clinical trial recruitment, access, and clinical operations. His work bridges clinical excellence and innovative technology to reimagine patient-centered care. His publications in Circulation, JAMA Cardiology, NEJM AI, and JAMA detail his use of technology to enhance the effectiveness and efficiency of healthcare delivery and evidence generation. 
Charles Boorady
(Speaker)
is the CEO and Managing Partner of Health Catalyst Capital Management, LLC (HCC), a New York–based investment firm focused on transformative healthcare companies applying artificial intelligence and information technology to improve access, quality, and cost of care. He founded HCC in 2015, bringing decades of experience at the intersection of healthcare, technology, and finance. Since inception, HCC has evaluated more than 15,000 private healthcare companies and manages a portfolio of over 20 investments with an aggregate enterprise value exceeding $10 billion. Charles has been investing in healthcare since 1994, including senior roles in investment banking and research at Goldman Sachs and Citi. He has advised, invested in, and served as chairman or director of healthcare and health IT companies from early-stage through IPO. As an equity analyst, he ranked #1 nationally for Managed Care and Health Care Providers, earning recognition from Institutional Investor and Forbes’ “Dazzling Dozen.” Charles holds an MBA from the University of Chicago Booth School of Business and a BS in Engineering from Cornell University. 
Umair A. Shah, MD, MPH
(Speaker)
is a physician executive and nationally recognized public health leader with more than 20 years of experience advancing population health, health system transformation, and innovation. He currently serves as Chief Medical Officer at Jaan Health, supporting Phamily, an AI‑enabled, proactive care platform focused on improving access, outcomes, and patient experience. Previously, Dr. Shah served as Secretary of Health for Washington State (2020–2025), leading a $3 billion agency that served 8 million residents. Under his leadership, Washington ranked among the nation’s healthiest states and achieved one of the lowest COVID‑19 mortality rates, while launching nationally recognized initiatives in digital health, data modernization, and public‑private collaboration. Earlier, he led Harris County Public Health in Texas and spent two decades as an emergency physician, including service at the Michael E. DeBakey VA Medical Center. He later founded Rickshaw Health, advising governments and health systems globally. Dr. Shah has held national leadership roles with the National Academies, CDC advisory bodies, and NACCHO, and is a recipient of the APHA Milton and Ruth Roemer Prize. He holds degrees from Vanderbilt University, the University of Toledo, and UTHealth. Dr. Shah holds numerous academic appointments across the nation including at Columbia’s Mailman School of Public Health.